Welcome to our dedicated page for Celestica SEC filings (Ticker: CLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Celestica’s 10-K runs hundreds of pages, packed with ATS versus CCS revenue splits, aerospace contract milestones, and intricate supply-chain risk factors. Finding segment margins or tracking when executives trade around server platform launches can feel like looking for a diode on a crowded PCB.
Stock Titan solves that problem. Our AI reads every line the moment it hits EDGAR, turning Celestica SEC filings explained simply from wishful thinking into reality. Need the Celestica quarterly earnings report 10-Q filing? You’ll see key backlog shifts and capital-equipment demand in seconds. Curious about a sudden management trade? Receive alerts on Celestica Form 4 insider transactions real-time and review concise tables summarizing each deal.
Here’s what you’ll uncover faster than scrolling a single PDF:
- Celestica insider trading Form 4 transactions that spotlight confidence—or caution—before major defense orders.
- AI-driven Celestica earnings report filing analysis comparing ATS gross margin to prior quarters.
- Clear guidance for understanding Celestica SEC documents with AI, including glossary links for complex supply-chain terms.
- Celestica annual report 10-K simplified with segment performance visuals you can export.
- Drill-downs into the Celestica proxy statement executive compensation to benchmark incentive metrics.
- Instant summaries of Celestica 8-K material events explained, from factory expansions to cloud-server design wins.
Whether you monitor Celestica executive stock transactions Form 4 for sentiment shifts or compare quarterly cash flows, Stock Titan’s real-time updates and plain-English insights turn complex disclosures into actionable knowledge.
Luis A. Muller, a director of Celestica Inc. (CLS), reported acquisition of 325 director share units on 09/30/2025. These units are a contingent right to receive one common share each or an equivalent cash value when the holder stops serving as a director, consultant or other service provider. After the reported transaction, Mr. Muller beneficially owns 849 common shares directly. The Form 4 was signed on behalf of the reporting person by attorney-in-fact Tracy Connelly McGilley on 10/01/2025. The filing lists the reporting persons address as 5140 Yonge Street, Suite 1900, Toronto, M2N 6L7.
Maletira Amar, a director of Celestica Inc. (CLS), acquired 289 director share units on 09/30/2025. Each unit is a contingent right to receive one common share or cash equivalent when the holder ceases to serve the issuer as a director, consultant, or service provider. The reported transaction shows 755 common shares beneficially owned following the award. The units carry no purchase price ($0) and were reported on Form 4 with a signature executed by an attorney-in-fact on 10/01/2025.
Celestica director Francoise Colpron received 155 director share units on 09/30/2025, increasing her direct beneficial ownership to 404 common shares. Each director share unit is a contingent right to one common share or cash equivalent at the issuer's discretion when the holder stops serving as a director or other service provider. The units were granted at no cash price and are recorded as an acquisition on Form 4. The filing was signed by an attorney-in-fact on 10/01/2025. This disclosure reflects a routine equity grant to a non-employee director rather than an open-market purchase.
Robert Cascella, a director of Celestica Inc. (CLS), was granted 157 restricted share units (RSUs) on 09/30/2025. Each RSU represents a contingent right to one common share or equivalent cash at the holder's election. The grant vests one-third annually over three years beginning on the anniversary of the grant. Following the grant the reporting person beneficially owns 157 common shares (direct). The RSUs were granted at a $0 per-unit price (no cash paid by the reporting person) and are subject to the stated vesting schedule.
Celestica Inc. director Kulvinder Ahuja received 144 director share units on 09/30/2025 under a non‑derivative award that vests to one common share (or cash equivalent) when the holder ceases service. The reported acquisition shows a $0 price per unit, and following the grant Ahuja beneficially owns 377 common shares in direct form. The filing was submitted on 10/01/2025 and signed by an attorney‑in‑fact. The director share unit plan creates a contingent right to receive common shares or cash at termination of service.
Michael Max Wilson, a director of Celestica Inc. (CLS), reported multiple awards and acquisitions on 06/30/2025. The Form 4 shows a direct acquisition of 5,890 common shares (transaction code M) at $0, increasing his direct beneficial ownership to 13,391 shares. The filing also reports vesting/awards of restricted share units (RSUs) totaling 5,890 RSUs across grants from 2022–2024 and 671 director share units granted/recorded, with underlying common-share equivalents and post-transaction holdings listed for each tranche.
The RSU grants are subject to time-based vesting schedules (one-third annually) as described for grants dated June 30 of 2022, 2023 and 2024. The Form 4 was signed by an attorney-in-fact, Tracy Connelly McGilley, on 07/01/2025.
Michael Max Wilson, a director of Celestica Inc. (CLS), reported transactions dated 03/31/2025 on Form 4. The filing shows an acquisition of 5,717 common shares (transaction code M) resulting in 7,501 common shares beneficially owned directly after the reported non-derivative transaction. The filing also records multiple equity award movements: RSU grants or vesting events of 2,517, 2,440, and 760 restricted share units (RSUs) and an acquisition of 1,300 deferred share units (DSUs). The explanatory notes clarify each RSU and DSU represents a contingent right to receive one common share or cash equivalent under specified conditions.
Insider sale and filing correction at Celestica (CLS). The Form 4 shows director Michael Max Wilson sold 25,000 common shares on 01/06/2025 at a weighted average price of $98.73 per share (price converted from CAD). After the disposition the report shows 1,784 shares beneficially owned directly. The filing also corrects prior reporting by including 9,117 shares that were omitted from a Form 3 filed 12/19/2024. The transaction was signed by an attorney-in-fact on 01/08/2025.
Michael Max Wilson, a director of Celestica Inc. (CLS), reported multiple equity award transactions on Form 4 dated 12/31/2024. The filing shows an acquisition of 6,697 common shares (code M) resulting in 17,667 shares beneficially owned after the transaction. The report also lists several restricted share unit (RSU) transactions: purchases/acquisitions of 2,795, 2,735, 1,167, and 1,092 RSUs on 12/31/2024, with corresponding beneficial ownership counts shown as 0, 2,736, 2,333, and 1,092 common shares respectively. The explanatory notes confirm the RSUs were annual grants from 2021 through 2024 and vest one-third annually over three years.
Michael Max Wilson, a director of Celestica Inc. (CLS), filed an initial Form 3 reporting ownership of 10,970 common shares directly and multiple equity award units. The filing lists 283,131 deferred share units convertible to common shares or cash on departure and a series of restricted share units granted between 2021 and 2024 totaling reported award amounts by grant: 8,386; 7,550; 9,448; 10,920; 8,207; 7,318; 6,437; 4,042; 3,500; 2,280; 1,787; 2,006, each with vesting schedules described in the filing.
FAQ
What is the current stock price of Celestica (CLS)?
What is the market cap of Celestica (CLS)?
